Search Page
Save citations to file
Email citations
Send citations to clipboard
Add to Collections
Add to My Bibliography
Create a file for external citation management software
Your saved search
Your RSS Feed
Filters
Results by year
Table representation of search results timeline featuring number of search results per year.
Year | Number of Results |
---|---|
2021 | 1 |
2022 | 1 |
2023 | 1 |
2024 | 0 |
Search Results
3 results
Results by year
Filters applied: . Clear all
It looks like you are searching for an author.
Results are currently sorted by Best Match. To see the newest results first,
change the sort order to Most Recent.
Page 1
Combined BCL-2 and PI3K/AKT Pathway Inhibition in KMT2A-Rearranged Acute B-Lymphoblastic Leukemia Cells.
Int J Mol Sci. 2023 Jan 10;24(2):1359. doi: 10.3390/ijms24021359.
Int J Mol Sci. 2023.
PMID: 36674872
Free PMC article.
Combined Application of Pan-AKT Inhibitor MK-2206 and BCL-2 Antagonist Venetoclax in B-Cell Precursor Acute Lymphoblastic Leukemia.
Richter A, Fischer E, Holz C, Schulze J, Lange S, Sekora A, Knuebel G, Henze L, Roolf C, Murua Escobar H, Junghanss C.
Richter A, et al. Among authors: holz c.
Int J Mol Sci. 2021 Mar 9;22(5):2771. doi: 10.3390/ijms22052771.
Int J Mol Sci. 2021.
PMID: 33803402
Free PMC article.
Item in Clipboard
Effective tumor cell abrogation via Venetoclax-mediated BCL-2 inhibition in KMT2A-rearranged acute B-lymphoblastic leukemia.
Richter A, Lange S, Holz C, Brock L, Freitag T, Sekora A, Knuebel G, Krohn S, Schwarz R, Hinz B, Murua Escobar H, Junghanss C.
Richter A, et al. Among authors: holz c.
Cell Death Discov. 2022 Jul 1;8(1):302. doi: 10.1038/s41420-022-01093-3.
Cell Death Discov. 2022.
PMID: 35778418
Free PMC article.
Item in Clipboard
Cite
Cite